Medicare Enrolled

Dr. Nazee Farsi, MD

Rheumatology · Irvine, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2224 MOLINO, Irvine, CA 92618
9493404652
In practice since 2007 (18 years)
NPI: 1386826881 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Farsi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Farsi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Farsi

Dr. Nazee Farsi is a rheumatology specialist in Irvine, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Farsi performed 214 Medicare services across 131 unique beneficiaries.

Between the years covered by Open Payments, Dr. Farsi received a total of $6,379 from 23 pharmaceutical and/or device companies across 286 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Farsi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ 214 Medicare services $6,379 industry payments

Medicare Practice Summary

Medicare Utilization ↗
214
Medicare services
Bottom 23% in CA for rheumatology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
131
Unique beneficiaries
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~12 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
148 $88 $200
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
24 $40 $240
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
24 $19 $40
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
18 $122 $300
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,379
Total received (2018-2024)
Avg $911/year across 7 years
Top 36% in CA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
23
Companies
286
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,592 (87.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$619 (9.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$168 (2.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$949
2023
$661
2022
$1,021
2021
$683
2020
$436
2019
$1,626
2018
$1,002

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$261
Novartis Pharmaceuticals Corporation
$236
Janssen Biotech, Inc.
$149
GlaxoSmithKline, LLC.
$108
UCB, Inc.
$49
Lilly USA, LLC
$42
ANI Pharmaceuticals, Inc.
$29
ABBVIE INC.
$22
Sandoz Inc.
$21
Boston Scientific Corporation
$17
PFIZER INC.
$16
Top 3 companies account for 68.1% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$1,240
Amgen Inc.
$1,116
Horizon Therapeutics plc
$924
Lilly USA, LLC
$494
Novartis Pharmaceuticals Corporation
$375
GlaxoSmithKline, LLC.
$328
UCB, Inc.
$302
Janssen Scientific Affairs, LLC
$229
ABBVIE INC.
$222
Celgene Corporation
$188
AbbVie, Inc.
$177
Genentech USA, Inc.
$154
Aurinia Pharma U.S., Inc.
$140
AstraZeneca Pharmaceuticals LP
$125
GENZYME CORPORATION
$119
AbbVie Inc.
$88
PFIZER INC.
$60
ANI Pharmaceuticals, Inc.
$29
Sandoz Inc.
$21
Boston Scientific Corporation
$17
Bioventus LLC
$14
Horizon Pharma plc
$12
SANOFI-AVENTIS U.S. LLC
$6
Top 3 companies account for 51.4% of all-time payments
Associated products mentioned in payments ›
AVSOLA · BENLYSTA · Bimzelx · COSENTYX · Cimzia · EVENITY · Enbrel · GELSYN 3 · HUMIRA · HYRIMOZ · Humira · KEVZARA · KRYSTEXXA · LUPKYNIS · NUCALA · Otezla · PURIFIED CORTROPHIN GEL · Prolia · REMICADE · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · TALTZ · TEPEZZA · TREMFYA · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in Irvine?
Compare rheumatologists in the Irvine area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
79
Per 100K population
2.5
County median income
$113,702
Nearest hospital
HOAG ORTHOPEDIC INSTITUTE
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Farsi is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Farsi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Farsi performed 148 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Farsi receive payments from pharmaceutical companies?
Yes. Dr. Farsi received a total of $6,379 from 23 companies across 286 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Farsi's costs compare to other rheumatologists in Irvine?
Dr. Farsi's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Farsi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →